PharmaLink, Inc.
PharmaLink is a U.S. pharmaceutical reverse logistics provider serving manufacturers, wholesalers, retail pharmacies, hospitals, government facilities, and consumers with proprietary Encore® and IMPRS platforms for returns processing, recall management, DSCSA compliance, and drug disposal.
- Company typePrivate
- Founded2000
- HeadquartersLargo, United States
- Headcount—
- GTM typeB2B
- OfferingServices
What PharmaLink, Inc. does
PharmaLink, Inc. is a U.S. pharmaceutical reverse logistics and disposal company founded in 2000 and headquartered in Largo, Florida. The company operates a single-flagship model: returns are shipped to or picked up from customers, then processed at a centralized 150,000 sq ft (and growing) facility in Largo under DEA, EPA, DOT, NABP/VAWD, and SOC 1 certifications, with state licensure across all 50 states plus Puerto Rico. Its service portfolio covers the full healthcare supply chain — pharmaceutical manufacturers, wholesalers, retail pharmacies (independent, chain, 340B, specialty), hospitals and IDNs, government facilities (VA, IHS, BOP), and consumers — and includes returns processing, recall management, controlled substance handling (Schedule II–V), DSCSA compliance, and consumer drug takeback.
The technology backbone centers on the proprietary Encore® web-based reporting and inventory platform and the IMPRS (Internet Managed Product Returns Solution) platform acquired in 2023 from Cybornetic Systems/PharmaReturns, which adds AI-driven customization for manufacturer returns processing. MedFlats®, eBudget, RxTakeBack®, and a DSCSA Compliance module built on the TraceLink partnership extend the product surface. The facility incorporates Exacta Acculight put-to-light/pick-to-light systems, Kardex Megamat vertical carousel storage, and a planned November 2025 automation rollout designed to more than double throughput.
The business model is primarily transaction-fee-based returns processing supplemented by professional services for recalls and subscription/recurring revenue for DSCSA compliance. GTM is sales-led via enterprise field sales for large accounts and an inside sales/Customer Solutions team for mid-market and SMB customers, supported by self-service web portals and a nationwide on-site plus mail-in servicing model. Key enterprise/government customers include Merck Sharp & Dohme, Amgen, the VA, the Indian Health Service, and the Bureau of Prisons; the IMPRS platform supports 400+ pharmaceutical manufacturers and thousands of healthcare facilities overall. PharmaLink received a growth investment from WestView Capital Partners in August 2025.
PharmaLink, Inc. firmographics
Firmographics- Name
- PharmaLink, Inc.
- Legal name
- PharmaLink, Inc.
- Website
- https://pharmalinkinc.com
- Company type
- Private
- Founded year
- 2000
- Operating status
- Operating
- Short description
- PharmaLink is a U.S. pharmaceutical reverse logistics provider serving manufacturers, wholesalers, retail pharmacies, hospitals, government facilities, and consumers with proprietary Encore® and IMPRS platforms for returns processing, recall management, DSCSA compliance, and drug disposal.
- Ownership category
- akta.pro rank
PharmaLink, Inc. industry classification
Industry- Product category
- Pharmaceutical Reverse Logistics
- NAICS
- Drugs and Druggists' Sundries Merchant Wholesalers (424210)
- SIC
- Wholesale-Drugs, Proprietaries & Druggists' Sundries (5122)
- akta.pro primary industry
- Pharmacy Logistics, Returns, Reverse Distribution & Compliance Services (CRAOAHAJ)
- akta.pro secondary industries
- Medication Inventory, Procurement & Supply Chain (Pharmacy) (HLACAKAI), Pharmaceutical Waste Management (RCRA/Non-RCRA, Take-Back) (BPALAGAF), Pharmacy Supply Chain & Secondary Distribution (Repackagers/Redistributors) (CRAOAHAC)
Keywords
Where PharmaLink, Inc. is headquartered
LocationHeadquarters
- HQ city
- Largo
- HQ country
- United States
- HQ region
- North America
Offices3 records
Markets served
PharmaLink, Inc. business model
Business model- GTM type
- B2B
- Offering type
- Services
- Cost components
- Personnel, Operations, Technology or R&D, Marketing or Sales, Infrastructure, Supply Chain
Revenue model
- Returns Processing Services: PharmaLink charges for processing returned and expired pharmaceutical products, handling the entire reverse logistics process including inspection, credit determination, and product disposition. Services are available for manufacturers, wholesalers, retail pharmacies, hospitals, and government facilities.
- Recall Management Services: Comprehensive services for notification, product retrieval, processing, storage, and disposal of recalled products from the healthcare supply chain.
- DSCSA Compliance Solutions: Turnkey compliance solutions for dispensers through TraceLink partnership, enabling electronic exchange of compliance data with drug suppliers.
- Mail-In Returns Program: Web-based inventory creation and reporting application with shipping of products to processing center, online DEA form preparation, and detailed processing reports.
- On-Site Returns Servicing: On-site product inventories and arrangements for free shipping of product back to returns facility for high-volume pharmacies.
Go-to-market motion2 records
Distribution channels5 records
Marketing channels5 records
PharmaLink, Inc. product offering
Product offeringCore offering
PharmaLink is a pharmaceutical reverse distribution and disposal company that processes expired, damaged, and recalled pharmaceuticals for manufacturers, wholesalers, retail pharmacies, hospitals, and government facilities. The company provides returns processing, recall management, controlled substance disposal, and DSCSA regulatory compliance services through its proprietary Encore web-based reporting platform and a 150,000 sq ft processing facility.
Product overview
PharmaLink, Inc. is a pharmaceutical reverse logistics and disposal provider offering a unified platform centered on its Encore® web-based reporting system, complemented by specialized returns processing services across all supply chain segments. The portfolio includes core service offerings for manufacturers, wholesalers, retail pharmacies (independent, chain, 340B, specialty), hospitals/IDNs, government facilities, and consumers, supported by product-specific solutions including RxTakeBack® for consumer drug disposal, MedFlats® for simplified returns, and IMPRS (acquired technology) for AI-enhanced manufacturer processing. The company also offers Product Recall Solutions and DSCSA Compliance Solutions as specialized modules, all integrated through the Encore® platform for unified reporting and analytics.
Differentiator
Problem solved
Functional benefit
Brands
- Encore: Web-based inventory and reporting platform for managing returns and providing real-time status updates and credit reports
- RxTakeBack
- MedFlats
- eBudget
- IMPRS
Products and services
- Manufacturer Returns Processing Services Comprehensive reverse distribution processing services for pharmaceutical manufacturers handling non-salable returned products, including returns management, regulatory compliance, product assessment, product disposal, documentation and reporting, supply chain optimization, and DSCSA-compliant serial number decommissioning.
- Wholesaler Returns Processing Services Complete reverse logistics solutions for wholesalers including VAWD-accredited operations, Encore web-based inventory management, NABP-accredited drug distributor services, distribution center return programs, logistics and ASN integration, and customer non-saleable returns programs.
- Retail Pharmacy Returns Services Returns processing services for independent pharmacies, 340B pharmacies, chain pharmacies, and specialty pharmacies, featuring on-site and mail-in servicing options, DEA controlled substance handling, DEA Form 222 preparation, and disposal services with personalized boutique service.
- Hospital and IDN Returns Services On-site and mail-in returns services for hospitals and Integrated Delivery Networks (IDNs) with personalized SOP-driven processes, DEA Form 222 completion, controlled substance handling, and maximum credit recovery.
- Government Returns Services Specialized returns processing services for government agencies including Veterans Affairs (VA), federal facilities, state dispensers, Indian Health Service, and Bureau of Prisons, offering tailored solutions for unique regulatory and contracting challenges.
- Product Recall Solutions Comprehensive recall management services including recall planning and strategy, execution, notification management, and product retrieval, processing, storage, and disposal from the healthcare supply chain.
- Encore Web-Based Reporting Platform Web-based inventory management and reporting platform providing real-time return inventory status, credit reports, data archiving, exporting capabilities, and analytics across all customer segments including pharmacies, wholesalers, and manufacturers.
- IMPRS (Internet Managed Product Returns Solution) AI-powered technology platform for returns processing that adds artificial intelligence and customization to the reverse distribution process for pharmaceutical manufacturers, supporting over 400 pharmaceutical manufacturers in the US.
- RxTakeBack Consumer Drug Disposal Program Consumer prescription drug takeback program providing safe and responsible disposal solutions for surplus prescription drugs, enabling pharmacies to comply with DEA Secure and Responsible Drug Disposal Act requirements.
- DSCSA Compliance Solutions Track-and-trace compliance solutions powered by TraceLink partnership, enabling dispensers to meet DSCSA requirements including serialized compliance data exchange in EPCIS format, supplier onboarding, VRS verification, and six-year data storage.
Quantifiable outcome
- 200%+ increase in processing capacity achieved through 2023 facility expansion
- +4 more outcomes
Companies that use PharmaLink, Inc.
Customer profileNamed customers12 records
Segments6 records
Ideal customer profiles5 records
PharmaLink, Inc. technology and API
TechnologyTechnology focussed No
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
Integration1 record
Feature7 records
PharmaLink, Inc. partnerships and signals
Strategic signalPartnerships
Five partnerships are on record, tiered core and minor.
- Recall Results, Inc.coreStrategic partnership to enhance drug safety and recall efficiency. Combines PharmaLink's reverse logistics expertise with Recall Results' specialized recall management technologies. Focuses on developing integrated systems to streamline recall processes with full ability to support recalls of any class down to patient level.
- PharmaReturns (Cybornetic Systems, Inc.)coreAcquisition of Cybornetic Systems, Inc. dba PharmaReturns, Inc. Provides innovative technology platform with AI and customization capabilities for reverse distribution. IMPRS platform supports 400+ pharmaceutical manufacturers. Integration of Encore® and IMPRS creates competitive advantage.
- TraceLinkcorePharmaLink partnered with TraceLink, the global leader in track-and-trace solutions, to provide the dispenser community with DSCSA compliance solutions. TraceLink enables dispensers to receive EPCIS format compliance data, onboard suppliers, store serialized compliance information, and initiate product verification through VRS.
- NACDS (National Association of Chain Drug Stores)minorPharmaLink joined NACDS, an international organization with 40,000+ pharmacy members, to participate in industry events and policy discussions.
- HDMA/HDA (Healthcare Distribution Management Association/Healthcare Distribution Alliance)minorPharmaLink joined HDMA (now HDA), a national association focused on developing efficient distribution systems, and became a Returns Taskforce member.
Scale indicators7 records
Recent moves22 records
Expansion highlights6 records
PharmaLink, Inc. competitors and assessment
Company assessmentBroad incumbents
- Cardinal Health: Cardinal Health is a major pharmaceutical wholesaler hosting its own RBC (Retail Business Conference) where PharmaLink exhibits. As a top-tier distributor, its in-house returns and reverse logistics capabilities overlap with PharmaLink's wholesaler and manufacturer offerings.
- Cencora (formerly AmerisourceBergen): Cencora is a top-three US pharmaceutical distributor offering returns and reverse logistics capabilities as part of its integrated services portfolio. It competes with PharmaLink in the wholesaler and manufacturer segments and could vertically integrate further into returns processing.
- McKesson Corporation: McKesson is the largest US pharmaceutical wholesaler and offers returns processing as part of its broader distribution services. As a vertically integrated incumbent, it represents both a customer (wholesaler channel) and a potential competitive threat to PharmaLink.
- Stericycle: Stericycle provides regulated waste management including pharmaceutical waste disposal, with EPA/DOT compliance infrastructure that overlaps with PharmaLink's disposal and RxTakeBack services. While not a returns processor, it competes in adjacent pharmaceutical waste streams.
Direct peers
- Capital Returns: Capital Returns provides pharmaceutical reverse distribution and returns processing services to manufacturers, wholesalers, and retail pharmacies in the US. It competes directly with PharmaLink across independent pharmacy, chain, and manufacturer returns.
- Inmar Inc. Inmar is the largest US pharmaceutical reverse distributor and most direct competitor to PharmaLink, offering returns processing, recall management, and supply-chain solutions across manufacturers, wholesalers, and pharmacies. Both companies compete for the same enterprise manufacturer and chain pharmacy accounts.
- Eco Pharma Solutions: Eco Pharma Solutions offers pharmaceutical waste management, returns processing, and disposal services. It competes with PharmaLink in the pharmaceutical disposal and DEA-compliant takeback segments, including the RxTakeBack consumer-facing channel.
- PharmaLogistics Ltd. PharmaLogistics is a North American pharmaceutical reverse distribution and returns processing company serving manufacturers, wholesalers, and pharmacies. Its service portfolio, customer base, and regulatory positioning closely mirror PharmaLink's core returns offering.
- RX Returns Services: RX Returns Services is a smaller pharmaceutical reverse distributor offering drug return and disposal services to retail pharmacies. It overlaps with PharmaLink's mail-in and on-site pharmacy returns offerings and competes on similar value propositions.
- Smith Drug Company (Verticore): Smith Drug Company / Verticore operates pharmaceutical distribution and reverse distribution services, including returns processing for retail and independent pharmacies. It overlaps with PharmaLink in pharmacy-channel returns processing and credit recovery.
Market position
Strengths5 records
Weaknesses5 records
Competitive moat5 records
Key risks6 records
Key highlights7 records
Customer concentration
PharmaLink, Inc. social profiles
Digital presencePharmaLink, Inc. compliance and trust
Trust signalCompliance8 records
PharmaLink, Inc. financial estimates
Financial estimateRevenue estimate
Valuation estimate
PharmaLink, Inc. leadership team
Management profileNumber of profiles
Profiles9 records
PharmaLink, Inc. subsidiaries and ownership
Company hierarchySubsidiaries3 records
PharmaLink, Inc. funding detail
Funding detailFunding overview
Funding rounds
Investors
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
PharmaLink, Inc. M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about PharmaLink, Inc.
What does PharmaLink, Inc. do?
PharmaLink is a pharmaceutical reverse distribution and disposal company that processes expired, damaged, and recalled pharmaceuticals for manufacturers, wholesalers, retail pharmacies, hospitals, and government facilities. The company provides returns processing, recall management, controlled substance disposal, and DSCSA regulatory compliance services through its proprietary Encore web-based reporting platform and a 150,000 sq ft processing facility.
Is PharmaLink, Inc. a public or private company?
PharmaLink, Inc. is a private company. It is classified as venture growth investor backed and is currently operating.
When was PharmaLink, Inc. founded?
PharmaLink, Inc. was founded in 2000.
Where is PharmaLink, Inc. based?
PharmaLink, Inc. is headquartered in Largo, United States, in the North America region.
How does PharmaLink, Inc. make money?
Five revenue lines are on record. Returns Processing Services are the primary driver. The others are recall Management Services, DSCSA Compliance Solutions, mail-In Returns Program and on-Site Returns Servicing.
Who are PharmaLink, Inc.'s main competitors?
Broad incumbents on record are Cardinal Health, Cencora (formerly AmerisourceBergen), McKesson Corporation and Stericycle. Direct peers are Capital Returns, Inmar Inc., Eco Pharma Solutions, PharmaLogistics Ltd., RX Returns Services and Smith Drug Company (Verticore).
Does PharmaLink, Inc. have an API?
No public API is recorded for PharmaLink, Inc..
What industry is PharmaLink, Inc. in?
PharmaLink, Inc.'s product category is Pharmaceutical Reverse Logistics. Its primary akta.pro industry code is CRAOAHAJ, Pharmacy Logistics, Returns, Reverse Distribution & Compliance Services, with a secondary code of HLACAKAI, Medication Inventory, Procurement & Supply Chain (Pharmacy). Its NAICS code is 424210 and its SIC code is 5122.